These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 29506127)
21. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani. Tripathi P; Jaiswal AK; Dube A; Mishra PR Int J Biol Macromol; 2017 Dec; 105(Pt 1):625-637. PubMed ID: 28716750 [TBL] [Abstract][Full Text] [Related]
22. Possible mechanism of miltefosine-mediated death of Leishmania donovani. Verma NK; Dey CS Antimicrob Agents Chemother; 2004 Aug; 48(8):3010-5. PubMed ID: 15273114 [TBL] [Abstract][Full Text] [Related]
23. Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis. Parvez S; Yadagiri G; Gedda MR; Singh A; Singh OP; Verma A; Sundar S; Mudavath SL Sci Rep; 2020 Jul; 10(1):12243. PubMed ID: 32699361 [TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity. Kumar D; Kulshrestha A; Singh R; Salotra P Antimicrob Agents Chemother; 2009 Feb; 53(2):835-8. PubMed ID: 19015344 [TBL] [Abstract][Full Text] [Related]
25. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death. Mishra J; Singh S Exp Parasitol; 2013 Oct; 135(2):397-406. PubMed ID: 23968687 [TBL] [Abstract][Full Text] [Related]
26. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445 [TBL] [Abstract][Full Text] [Related]
27. In silico studies and evaluation of antiparasitic role of a novel pyruvate phosphate dikinase inhibitor in Leishmania donovani infected macrophages. Kashif M; Hira SK; Upadhyaya A; Gupta U; Singh R; Paladhi A; Khan FI; Rub A; Manna PP Int J Antimicrob Agents; 2019 Apr; 53(4):508-514. PubMed ID: 30599242 [TBL] [Abstract][Full Text] [Related]
28. Leishmania donovani develops resistance to drug combinations. García-Hernández R; Manzano JI; Castanys S; Gamarro F PLoS Negl Trop Dis; 2012; 6(12):e1974. PubMed ID: 23285310 [TBL] [Abstract][Full Text] [Related]
29. Immunoprotective effect of lentinan in combination with miltefosine on Leishmania-infected J-774A.1 macrophages. Shivahare R; Ali W; Singh US; Natu SM; Khattri S; Puri SK; Gupta S Parasite Immunol; 2016 Oct; 38(10):618-27. PubMed ID: 27387601 [TBL] [Abstract][Full Text] [Related]
30. Leishmania resistance to miltefosine associated with genetic marker. Cojean S; Houzé S; Haouchine D; Huteau F; Lariven S; Hubert V; Michard F; Bories C; Pratlong F; Le Bras J; Loiseau PM; Matheron S Emerg Infect Dis; 2012 Apr; 18(4):704-6. PubMed ID: 22469394 [No Abstract] [Full Text] [Related]
31. Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis. Voak AA; Harris A; Qaiser Z; Croft SL; Seifert K Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630200 [TBL] [Abstract][Full Text] [Related]